Agilent Technologies (A) vs peers
A's EV/EBITDA is 27.5x, compared with 27.7x at the middle of 6 peers.
Life Sciences Tools & Services. Updated .
| Stock | EV/EBITDA | Own 5-year rank |
|---|---|---|
| AAgilent Technologies | 27.5x | 93% |
| CRLCharles River Laboratories | 49.0x | 100% |
| TECHBio-Techne | 32.5x | 35% |
| MTDMettler Toledo | 28.7x | 72% |
| TMOThermo Fisher Scientific | 26.7x | 100% |
| DHRDanaher Corporation | 24.5x | 61% |
| IQVIQVIA | 18.0x | 72% |
How to read this comparison
Up to eight covered companies in the same industry, largest market value first.
EV/EBITDA divides enterprise value (stock market value plus debt, less cash) by earnings before interest, tax, depreciation and amortization from the previous twelve months. The middle peer reading excludes A and unavailable values.
Own 5-year rank compares each stock with its available weekly readings within the last five years. At least 26 usable weeks are required. A rank of 20% means its current multiple is above 20% of its past readings. It is not a rank against the other stocks in this table.
Dates show data updates; the latest available weekly observation can differ between stocks. Different growth rates, margins and financial risks can explain different multiples. Missing or non-positive denominators are left unranked.